1. Membrane Transporter/Ion Channel Neuronal Signaling
  2. GABA Receptor
  3. Aminoxyacetic acid

Aminoxyacetic acid  (Synonyms: Carboxymethoxylamine; Aminooxyacetate)

Cat. No.: HY-107994A Purity: 95.0%
Handling Instructions Technical Support

Aminooxyacetic acid (Carboxymethoxylamine) is a malate-aspartate shuttle (MAS) inhibitor. Aminooxyacetic acid also inhibits the GABA degradating enzyme GABA-T.

For research use only. We do not sell to patients.

CAS No. : 645-88-5

Size Price Stock Quantity
1 mg In-stock
5 mg In-stock
10 mg In-stock
50 mg   Get quote  
100 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 24 publication(s) in Google Scholar

Other Forms of Aminoxyacetic acid:

Top Publications Citing Use of Products

    Aminoxyacetic acid purchased from MedChemExpress. Usage Cited in: Signal Transduct Target Ther. 2023 Feb 15;8(1):65.  [Abstract]

    Aminooxyacetic acid hemihydrochloride (AOA) (20 μM; 48 h) decreased the migration and invasion of HCC cells expressing p5372P variant.

    Aminoxyacetic acid purchased from MedChemExpress. Usage Cited in: Signal Transduct Target Ther. 2023 Feb 15;8(1):65.  [Abstract]

    A Parental or PSAT1 knockout PLC/PRF/5 cells were tail intravenously injected into BALB/c nude mice and the mice were treated with vehicle or Aminooxyacetic acid hemihydrochloride (AOA) (10 mg/kg; i.p.; once daily for 14 d). Aminooxyacetic acid hemihydrochloride (AOA) treatment significantly inhibited the lung metastasis of cancer cells expressing the p5372P variant in vivo.

    Aminoxyacetic acid purchased from MedChemExpress. Usage Cited in: Signal Transduct Target Ther. 2023 Feb 15;8(1):65.  [Abstract]

    The interaction between PSAT1 and p53 was diminished by Aminooxyacetic acid hemihydrochloride (AOA) (10-20 μM) treatment while the protein level of PSAT1 was not significantly changed.

    Aminoxyacetic acid purchased from MedChemExpress. Usage Cited in: Signal Transduct Target Ther. 2023 Feb 15;8(1):65.  [Abstract]

    Cell viability of Hep3B cells transfected with vector, p53-72P, and p53-72R plasmids was assessed. Cells were treated with regorafenib alone or Aminooxyacetic acid hemihydrochloride (AOA) (10 μM) plus regorafenib at indicated concentrations. Aminooxyacetic acid hemihydrochloride (AOA) sensitized tumor cells containing vector and p53-72P to regorafenib, while exhibiting no obvious synergistic function with regorafenib in cells containing p53-72R.

    Aminoxyacetic acid purchased from MedChemExpress. Usage Cited in: Nat Metab. 2022 Feb;4(2):239-253.  [Abstract]

    Aminooxyacetic acid hemihydrochloride (GOT1) (1 mM; 2 d). Cell proliferation of H460 cells was quantified after treatment with inhibitors against the indicated enzymes.
    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Aminooxyacetic acid (Carboxymethoxylamine) is a malate-aspartate shuttle (MAS) inhibitor. Aminooxyacetic acid also inhibits the GABA degradating enzyme GABA-T.

    IC50 & Target

    MAS[1], GABA-T[2]

    Cellular Effect
    Cell Line Type Value Description References
    HT-29 IC50
    140 μM
    Compound: AOAA
    Antiproliferative activity against human HT-29 cells assessed as decrease in cell viability after 24 hrs by CCK8 assay
    Antiproliferative activity against human HT-29 cells assessed as decrease in cell viability after 24 hrs by CCK8 assay
    [PMID: 30108705]
    HT-29 IC50
    159.2 μM
    Compound: AOAA
    Antiproliferative activity against human HT-29 cells after 24 hrs by CCK8 assay
    Antiproliferative activity against human HT-29 cells after 24 hrs by CCK8 assay
    [PMID: 30108905]
    HT-29 IC50
    286.7 μM
    Compound: AOAA
    Antiproliferative activity against human HT-29 cells harboring CBS SiRNA after 24 hrs by CCK8 assay
    Antiproliferative activity against human HT-29 cells harboring CBS SiRNA after 24 hrs by CCK8 assay
    [PMID: 30108905]
    In Vitro

    Aminooxyacetic acid hemihydrochloride (AOAA) dose-dependently decreases the survival of C6 glioma cells. Aminooxyacetic acid hemihydrochloride treatment produces a significant increase in the percentage of the cells arrested in the stage of G0/G1, as well as a significant decrease in the percentage of the cells at S phase and G2/M phase. Aminooxyacetic acid hemihydrochloride treatment leads to an obvious decrease in the number of the cells in the phase of cell division. Aminooxyacetic acid hemihydrochloride significantly increases the percentage of the cells in both early-stage apoptosis and necrosis. Treatment of the cells with 1 mM or 5 mM Aminooxyacetic acid hemihydrochloride leads to decreased levels of aging of the cells[1]. Glutamine-dependent cell lines show greater inhibition of cell growth by Aminooxyacetic acid hemihydrochloride (AOA) compare with cells that are less glutamine dependent[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    In Vivo

    The accumulation of GABA in cerebellum and whole brain is initially very rapid, being significantly increased already 5 min after the injection of Aminooxyacetic acid (AOAA). The rapid initial accumulation becomes gradually slower and maximal levels (400 to 600 % of the control levels) reached 2 to 6 h after Aminooxyacetic acid treatment. Still 24 h after Aminooxyacetic acid treatment, the GABA levels are elevated by about 250%. From 2 to 6 h after Aminooxyacetic acid treatment, the convulsions are completely blocked. 24 h after Aminooxyacetic acid treatment, the convulsions are almost identical to the controls[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Molecular Weight

    91.07

    Formula

    C2H5NO3

    CAS No.
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    O=C(O)CON

    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage
    Powder -20°C 3 years
    In solvent -80°C 6 months
    -20°C 1 month
    Purity & Documentation

    Purity: 95.0%

    References
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass   Concentration   Volume   Molecular Weight *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Aminoxyacetic acid
    Cat. No.:
    HY-107994A
    Quantity:
    MCE Japan Authorized Agent: